retinal imaging

RetinalGenix Technologies Inc. has appointed Dr. Taimour Langaee as a scientific advisor to advance its precision medicine initiatives. Dr. Langaee, an expert in pharmacogenomics, will lead efforts on the company’s DNA GPS Pharmacogenetics platform. This platform aims to personalize treatment pathways for retinal and systemic diseases by analyzing genetic data and linking eye diseases to genetic variations, furthering RetinalGenix’s commitment to early disease detection through advanced retinal imaging.